Washington Report - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Washington Report
123456789101112
Next »

Health IT Promises More Timely Drug Information

March 2, 2010
By:Jill Wechsler
Pharmaceutical Technology

FDA modernizes information systems, expands access to drug safety and use information.

Manufacturers Look to Vaccines for Growth and Innovation

February 2, 2010
By:Jill Wechsler
Pharmaceutical Technology

Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges.

Pharma Faces Multiple Challenges in the Year Ahead

January 2, 2010
By:Jill Wechsler
Pharmaceutical Technology

Globalization and reform initiatves will shape pharma production, pricing, and pipelines in 2010.

Generic Drugs Come of Age

December 2, 2009
By:Jill Wechsler
Pharmaceutical Technology

Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.

Safety versus Speed in Drug Development

November 2, 2009
By:Jill Wechsler
Pharmaceutical Technology

The heightened focus on risk raises concerns about delays in approving new drugs.

New Leadership Seeks to Transform FDA

October 2, 2009
By:Jill Wechsler
Pharmaceutical Technology

Strict enforcement, new rules, and organizational changes signal an activist tone.

Global Health Concerns Create Business Opportunities

September 2, 2009
By:Jill Wechsler
Pharmaceutical Technology

Health crises generate support for new vaccines and treatments for diseases found in developing nations.

Pharma Girds for Healthcare Reform

August 2, 2009
By:Jill Wechsler
Pharmaceutical Technology

Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.

Manufacturers Face New Risk-Management Requirements

July 2, 2009
By:Jill Wechsler
Pharmaceutical Technology

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.

123456789101112
Next »

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
When sourcing raw materials and non-GMP intermediates or other chemicals, where are the majority of your suppliers located?
In the United States
In Western Europe
In Central and Eastern Europe
In Japan
In India
In China
In the United States
18%
In Western Europe
19%
In Central and Eastern Europe
3%
In Japan
2%
In India
30%
In China
30%
View Results
Jim MillerOutsourcing OutlookJim Miller Time for a Model Upgrade
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Navigating the Global Pharmaceutical Supply Chain
Faiz kermaniSpotlightFaiz Kermani Reinvigorating European R&D innovation
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
FindPharma Custom Search
Featured Jobs

More Jobs

Click here